Showing results (321-330 of 417) with videos related to

Sort By:
Pageof 42
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Hepatology (Baltimore, Md.)|January 10, 2018
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosisJacqueline G O'Leary, K Rajender Reddy, Guadalupe Garcia-Tsao, et al.
Gastroenterology|April 14, 2009
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinomaJorge A Marrero, Ziding Feng, Yinghui Wang, et al.
Plos One|May 30, 2013
A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infectionDavid Gardiner, Jay Lalezari, Eric Lawitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2017
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine TransaminaseJu Dong Yang, Jianliang Dai, Amit G Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2016
Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ FailuresJasmohan S Bajaj, Jacqueline G O'Leary, Puneeta Tandon, et al.
Gastroenterology|August 24, 2024
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination ProgramMadhumita Premkumar, Radha K Dhiman, Ajay Duseja, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 24, 2025
Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascitesJasmohan S Bajaj, Ethan M Weinberg, K Rajender Reddy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 26, 2019
Impact of Chronic Kidney Disease on Outcomes in CirrhosisFlorence Wong, K Rajender Reddy, Jacqueline G O'Leary, et al.
Transplantation|January 11, 2018
Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan CriteriaBrett L Ecker, Maarouf A Hoteit, Kimberly A Forde, et al.
Pageof 42